Trump Administration Withdraws Key ADA Documents
By I. Edwards HealthDay Reporter
WEDNESDAY, April 9, 2025 -- The Trump administration has removed 11 guidance documents that helped businesses follow the Americans with Disabilities Act (ADA), a new report says.
The documents were withdrawn last month as part of a federal effort to reduce rules that businesses must follow.
The Department of Justice (DOJ) said the goal was to cut costs and boost the economy, The Associated Press reported.
“Putting money back into the pockets of business owners helps everyone by allowing those businesses to pass on cost savings to consumers and bolster the economy,” U.S. deputy assistant attorney general Mac Warner said in a statement.
But some disability experts say this decision could hurt people with disabilities. The guidance, while not legally required, helped businesses understand how to follow the ADA and avoid lawsuits.
A wide range of topics were covered, The AP reported. Some documents gave tips on making hotel rooms accessible, while other docs helped hospitals support disabled patients during COVID visitor bans.
There were also guides to accessible parking, stores and ways to help customers at gas stations.
Even though the ADA law itself hasn't changed, experts worry that removing these guides could confuse business owners and reduce access for disabled people.
“When your business is fully accessible to all people with all types of disabilities, they’re going to come. They’re going to spend their money,” Theo Braddy, the executive director of the advocacy group, the National Council on Independent Living, told AP.
Marc Dubin, a lawyer and ADA consultant in Big Pine Key, Fla., said the real question is whether the DOJ will offer new guidance in place of what was withdrawn. He added that guidance helps avoid expensive lawsuits by encouraging voluntary compliance.
Some businesses said the guidance opened the door for lawsuits.
“To the business owners, it’s saying, ‘You ain’t got to do all of this stuff,’ ” Braddy said. “It’s going to turn the clock back.”
The DOJ is supposed to enforce the ADA by investigating complaints and suing businesses when needed.
But advocates fear enforcement could weaken, leaving private lawyers to pick up the slack.
“It’s very clear to me that nothing can substitute for a strong, vigorous Department of Justice,” said Chai Feldblum, who served as the vice chair of President Joe Biden’s AbilityOne Commission, which created job opportunities for disabled people. “And not having that will be consequential for the rights of people with disabilities.”
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-04-10 06:00
Read more

- Sleep Deficiency Linked to Atrophy of the Inferior Parietal Region of the Brain
- AGA Finds No Clear Evidence for or Against AI-Assisted Colonoscopy
- ACP: Guidance Provided for Use of Cannabis in Chronic Noncancer Pain Management
- All-Cause Mortality Increased From 2020 to 2021 Nationwide
- Novo Nordisk To Pay $2 Billion for New Weight Loss Drug
- FDA Approves Novartis Radioligand Therapy Pluvicto for Earlier Use Before Chemotherapy in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions